Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 2 | -$0.35 | -$0.35 | -$0.35 |
Q2 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
Q3 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Q4 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
Q1 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q2 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
Q3 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q4 2026 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q1 2027 | 1 | -$0.16 | -$0.16 | -$0.16 |
Q2 2027 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q3 2027 | 1 | -$0.16 | -$0.16 | -$0.16 |
Q4 2027 | 1 | -$0.18 | -$0.18 | -$0.18 |
Q1 2028 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q2 2028 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q3 2028 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q4 2028 | 1 | -$0.09 | -$0.09 | -$0.09 |
Imunon, Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-0.36 by $0.13. The company had revenue of 727,160 for the quarter and had revenue of 0 for the year. Imunon, Inc. has generated $-1,618 earnings per share over the last year ($-1618 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Imunon, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/27/2025 | Q4 2024 | -$0.36 | $421.89 | 422.25 | $125,000 | $727,160 |
11/07/2024 | Q3 2024 | -$0.37 | -$335.44 | -335.07 | $125,000 | $0 |
08/14/2024 | Q2 2024 | -$0.55 | -$0.51 | 0.04 | $125,000 | $0 |
05/13/2024 | Q1 2024 | -$0.57 | -$0.52 | 0.05 | N/A | $0 |
03/28/2024 | Q4 2023 | -$0.59 | -$0.52 | 0.07 | N/A | $7.05 M |
09/29/2023 | Q3 2023 | N/A | -$0.37 | N/A | N/A | $0 |
08/10/2023 | Q2 2023 | -$0.71 | -$0.61 | 0.1 | N/A | $0 |
05/11/2023 | Q1 2023 | -$0.69 | -$8.75 | -8.06 | N/A | $0 |
03/30/2023 | Q4 2022 | -$0.80 | -$3.58 | -2.78 | N/A | $125,000 |
11/14/2022 | Q3 2022 | -$0.81 | -$0.86 | -0.05 | $108,333 | $125,000 |
06/30/2022 | Q2 2022 | N/A | -$0.88 | N/A | $108,333 | $125,000 |
03/31/2022 | Q1 2022 | -$0.90 | -$2.62 | -1.72 | N/A | $125,000 |
12/31/2021 | Q4 2021 | N/A | -$0.73 | N/A | N/A | $125,000 |
09/30/2021 | Q3 2021 | N/A | -$0.94 | N/A | $112,500 | $125,000 |
06/30/2021 | Q2 2021 | N/A | -$0.95 | N/A | $125,000 | $125,000 |
03/31/2021 | Q1 2021 | N/A | -$3.31 | N/A | N/A | $125,000 |
12/31/2020 | Q4 2020 | N/A | -$1.56 | N/A | N/A | $125,000 |
09/30/2020 | Q3 2020 | N/A | -$3.55 | N/A | $130,000 | $125,000 |
06/30/2020 | Q2 2020 | N/A | -$2.68 | N/A | $127,500 | $125,000 |
03/31/2020 | Q1 2020 | N/A | -$2.94 | N/A | N/A | $125,000 |
Imunon, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based offlast year's report dates.
In the previous quarter, Imunon, Inc. (:IMNN) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.36 by $0.13.
The conference call for Imunon, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Imunon, Inc.'s latest earnings report can be read online.
Imunon, Inc. (:IMNN) has a recorded net income of $-18,620,242,000.Imunon, Inc. has generated $-1618 earnings per share over the last four quarters.
Imunon, Inc. (:IMNN) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED